US 2024/0156871 A1Published application

Cytokine-induced killer cells

OwnerIngo Schmidt-Wolfinventor

Life of this patent

Estimating the term…

The present invention relates to cytokine induced Killer cells (CIKs) for use in the treatment of diseases caused by a Plasmodium infection.

Dependent claims

Use of cytokine-induced Killer (CIK) cells for the treatment of diseases caused by a Plasmodium infection in a patient in need thereof.

Dependencies are inferred from the claim text.

A61K 40/15
Characterised by the cell type used: natural-killer [NK] cells; Natural-killer T [NKT] cells
A61K 40/11
Characterised by the cell type used: t-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer…
A61K 40/421
Receptors, cell surface antigens or cell surface determinants: immunoglobulin superfamily
A61K 40/438
Protozoan antigens: hemosporidia antigens, e.g. Plasmodium antigens

No related US applications are recorded in the indexed filing history.

Loading patent…